DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/lpbk4b\/severe_psoriasis<\/a>) has announced the addition of the \"Severe Psoriasis - Pipeline Review, H2 2013\" report to their offering. <\/p>\n 'Severe Psoriasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Severe Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Severe Psoriasis. <\/p>\n Scope <\/p>\n - A snapshot of the global therapeutic scenario for Severe Psoriasis. <\/p>\n - A review of the Severe Psoriasis products under development by companies and universities\/research institutes based on information derived from company and industry-specific sources. <\/p>\n - Coverage of products based on various stages of development ranging from discovery till registration stages. <\/p>\n - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. <\/p>\n - Coverage of the Severe Psoriasis pipeline on the basis of route of administration and molecule type. <\/p>\n - Key discontinued pipeline projects. <\/p>\n <\/p>\n Read more: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/lpbk4b\/severe_psoriasis<\/a>) has announced the addition of the \"Severe Psoriasis - Pipeline Review, H2 2013\" report to their offering. Continue reading
\nResearch and Markets: Severe Psoriasis - Pipeline Review, H2 2013<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"